Centre for Cellular and Molecular Platforms (C-CAMP) and Siemens Healthineers have formed a partnership to explore synergies in innovation and entrepreneurship development in healthcare domain with specific focus on Diagnostics, a core strength of both partners.
The agreement’s primary aim is to combine the technical expertise and scientific resources built by C-CAMP and Siemens Healthineers to enable common access to state-of-the-art diagnostics assays, clinical testing capacities, artificial intelligent (AI) technology, hardware and software automation solutions that align with local needs and local ecosystems.
The MoU was signed by C-CAMP CEO & Director, Dr Taslimarif Saiyed and Dileep Mangsuli, Executive Director, Siemens Healthineers at a ceremonial event held at C-CAMP on 23 September.
The partnership formalized for a year, will focus on diagnostics in point-of-care, in vitro or laboratory testing, imaging & genomics, CRISPR-Cas testing etc. with possibilities in antibiotic susceptibility, antimicrobial resistance, onco-assays and biomarkers, and AI-based rapid triaging.
